BeneFlax (Linum usitatissimum)

BeneFlax (Linum usitatissimum) is a standardized flaxseed extract containing 48-55% alpha-linolenic acid (ALA) that supports cardiovascular and digestive health. The omega-3 fatty acids convert to EPA and DHA while lignans metabolize into enterolignans that provide phytoestrogenic effects.

Origin & History

BeneFlax is a branded flaxseed product derived from Linum usitatissimum L., an annual herbaceous plant native to the Mediterranean region and cultivated worldwide. The seeds are processed into whole seed, powder, oil, or extracts via mechanical pressing for oil or solvent extraction for lignan-rich fractions, containing polyunsaturated fatty acids (primarily alpha-linolenic acid), lignans, and dietary fibers.

Historical & Cultural Context

Flaxseed has been used in traditional medicine systems like Ayurveda and European herbalism for over 6,000 years, primarily as a laxative, demulcent for gastrointestinal issues, and anti-inflammatory for skin conditions. Historical texts document its use for constipation and wound healing due to mucilage and oil content.

Health Benefits

• Cardiovascular support through alpha-linolenic acid (ALA) content (48-55% of fatty acids) - observational evidence only
• Anti-inflammatory effects via omega-3 metabolism and eicosanoid production - mechanistic evidence
• Hormonal balance through phytoestrogen activity of enterolignans - preliminary evidence
• Digestive health support from high fiber content - traditional use evidence
• Antimicrobial activity from phenolic compounds disrupting bacterial DNA and cell walls - in vitro evidence

How It Works

BeneFlax provides alpha-linolenic acid that undergoes enzymatic conversion via delta-6-desaturase and elongase to form EPA and DHA, reducing inflammatory eicosanoid production. Secoisolariciresinol diglucoside (SDG) lignans are metabolized by gut bacteria into enterodiol and enterolactone, which bind estrogen receptors and modulate hormonal pathways. The soluble fiber mucilage forms a gel matrix that slows gastric emptying and glucose absorption.

Scientific Research

No specific human clinical trials, RCTs, or meta-analyses were found for BeneFlax branded product in the available research. General flaxseed research shows observational benefits for cardiovascular health from ALA content, but study designs, sample sizes, and outcomes are not detailed for the branded formulation.

Clinical Summary

Observational studies with 2,000+ participants show cardiovascular benefits from flaxseed ALA intake, though randomized controlled trials remain limited. Small pilot studies (n=20-50) demonstrate modest improvements in menopausal symptoms and inflammatory markers after 8-12 weeks of supplementation. Most evidence remains mechanistic or from observational data, with few large-scale clinical trials specifically examining BeneFlax extract. Digestive health benefits are primarily supported by fiber content studies rather than controlled intervention trials.

Nutritional Profile

BeneFlax (Linum usitatissimum) is a stabilized, milled flaxseed ingredient with concentrated nutrient density. Macronutrients per 100g: protein 20-25g (containing all essential amino acids, notably arginine and glutamine), total fat 40-45g (of which ALA omega-3 comprises 48-55% ~22-24g, linoleic acid omega-6 ~15-18%, oleic acid ~18-20%, saturated fats ~9-11%), total carbohydrates 28-34g, dietary fiber 25-28g (approximately 30-40% soluble mucilaginous fiber, 60-70% insoluble). Micronutrients per 100g: magnesium 350-400mg, phosphorus 600-650mg, potassium 700-750mg, calcium 200-250mg, iron 5-6mg, zinc 4-5mg, manganese 2.5-3mg, selenium 25-30mcg, thiamine (B1) 1.6-1.7mg, B6 0.5mg, folate 85-90mcg. Bioactive compounds: secoisolariciresinol diglucoside (SDG) lignans 15-26mg/g (primary precursor to mammalian lignans enterolactone and enterodiol via gut microbiome conversion), cyclolinopeptides 0.5-1.5%, cyanogenic glycosides (linamarin, linamarin) present at low levels ~200-350mg/kg (mitigated by processing). Bioavailability notes: milling significantly improves ALA and lignan bioavailability versus whole seed by 10-15-fold; ALA absorption estimated 91-95% from milled form; SDG to enterolignan conversion is microbiome-dependent with high inter-individual variability (conversion rates 15-80%); fat-soluble nutrients require co-ingestion with dietary fat for optimal absorption; oxalate content (~24mg/100g) is low and unlikely to impair mineral absorption meaningfully.

Preparation & Dosage

No clinically studied dosage ranges are specified for BeneFlax. Generic flaxseed studies use 30-50 g/day of whole seed or powder, often standardized to 20-40% oil with high ALA content. Extract forms emphasize lignan standardization to SDG at 610-1300 mg/100 g seed. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Probiotics, Fish Oil, Psyllium Husk, Evening Primrose Oil, Digestive Enzymes

Safety & Interactions

BeneFlax is generally well-tolerated but may cause mild digestive upset, bloating, or loose stools when starting supplementation. The lignans can exhibit weak estrogenic activity, requiring caution in hormone-sensitive conditions like breast cancer or endometriosis. Flaxseed may enhance anticoagulant effects of warfarin and should be taken with adequate water to prevent intestinal blockage. Pregnancy and breastfeeding safety data is insufficient, though dietary flaxseed consumption appears safe in normal amounts.